AANS Neurosurgeon | Volume 26, Number 4, 2017


Targeting Parkinson's-linked Protein Could Neutralize 2 of the Disease's Causes

Mouse and human cell studies confirm a common link between proteins and loss of dopamine-making brain cells 

Researchers report they have discovered how two problem proteins known to cause Parkinson’s disease are chemically linked, suggesting that someday, both could be neutralized by a single drug designed to target the link. The investigators’ new experiments build on evidence reported in 2011 that reducing the amount of a protein called PARIS in mice with the rodent equivalent of Parkinson’s disease protects against the loss of dopamine-making neurons. Since then, according to Ted Dawson, MD, PhD, professor of neurology and director of the Institute for Cell Engineering at the Johns Hopkins University School of Medicine, the research team suspected PARIS was linked chemically to other important Parkinson’s proteins. “In this study, we were able to confirm that suspicion,” he says. Dawson explains that a hallmark of Parkinson’s disease is the death of brain cells that produce the signaling molecule, or neurotransmitter, dopamine. Dopamine depletion, in turn, causes the classic symptoms of Parkinson’s disease, such as tremors, muscle stiffness and lack of muscle coordination. Mutations in the gene for a protein called Parkin are known to cause the death of dopamine neurons; less commonly, defects in another protein, PINK1, can have the same effect.

Click here to read more.


Winter Clinics for Cranial and Spinal Surgery
Feb. 25, 2018 - Mar. 1, 2018; Snowmass Village, Colo.

69th Southern Neurosurgical Society Annual Meeting
Feb. 28, 2018 - Mar. 3, 2018; San Juan, PR

Second International Brain Mapping Course
April 26-27, 2018; New Orleans

Comments are closed.